Positron Corp. Stock Analysis POSC
Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.
Read More Positron Corp (POSC) Chart
Key Statistics of Positron Corp (POSC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.82Volume
24.75KP/E Ratio (TTM)
-52 Week Range
Market Cap
62.41MAvg. Volume
40.03KDividend Yield
-Financial Metrics & Statements of Positron Corp (POSC)
FAQ's for Positron Corp (POSC)
- According to Musaffa’s Shariah screening methodology, Positron Corp (POSC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.